ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,570,932 | -7.5% | 13,200 | +38.5% | 0.00% | 0.0% |
| Q2 2023 | $1,698,329 | +22.6% | 9,531 | +13.5% | 0.00% | 0.0% |
| Q1 2023 | $1,385,532 | +18.7% | 8,399 | +13.3% | 0.00% | 0.0% |
| Q4 2022 | $1,166,958 | -5.6% | 7,410 | -9.7% | 0.00% | 0.0% |
| Q3 2022 | $1,236,000 | -13.4% | 8,210 | -5.5% | 0.00% | 0.0% |
| Q2 2022 | $1,428,000 | -31.6% | 8,685 | -7.5% | 0.00% | 0.0% |
| Q1 2022 | $2,089,000 | +8.2% | 9,385 | +15.4% | 0.00% | 0.0% |
| Q4 2021 | $1,930,000 | +1.4% | 8,132 | -0.3% | 0.00% | 0.0% |
| Q3 2021 | $1,903,000 | +1.0% | 8,155 | -10.9% | 0.00% | 0.0% |
| Q2 2021 | $1,884,000 | +0.1% | 9,153 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $1,882,000 | -2.4% | 9,162 | +1.9% | 0.00% | 0.0% |
| Q4 2020 | $1,929,000 | +12.9% | 8,993 | -3.8% | 0.00% | -50.0% |
| Q3 2020 | $1,708,000 | -49.3% | 9,347 | -48.9% | 0.00% | -33.3% |
| Q2 2020 | $3,370,000 | -26.6% | 18,287 | -19.7% | 0.00% | -40.0% |
| Q1 2020 | $4,593,000 | +16.4% | 22,763 | +7.9% | 0.01% | +25.0% |
| Q4 2019 | $3,946,000 | +14.9% | 21,087 | -2.0% | 0.00% | 0.0% |
| Q3 2019 | $3,434,000 | -38.9% | 21,516 | -3.5% | 0.00% | -42.9% |
| Q2 2019 | $5,616,000 | +10.4% | 22,295 | +4.9% | 0.01% | 0.0% |
| Q1 2019 | $5,088,000 | +16.0% | 21,258 | +11.3% | 0.01% | 0.0% |
| Q4 2018 | $4,385,000 | +258.3% | 19,094 | +358.0% | 0.01% | +133.3% |
| Q2 2018 | $1,224,000 | +10.4% | 4,169 | -5.1% | 0.00% | 0.0% |
| Q1 2018 | $1,109,000 | -45.0% | 4,394 | -53.0% | 0.00% | -25.0% |
| Q4 2017 | $2,018,000 | +3.4% | 9,343 | -11.0% | 0.00% | -20.0% |
| Q3 2017 | $1,951,000 | +4.4% | 10,500 | -3.0% | 0.01% | 0.0% |
| Q2 2017 | $1,868,000 | +39.4% | 10,830 | +23.3% | 0.01% | +25.0% |
| Q1 2017 | $1,340,000 | -3.2% | 8,787 | -6.6% | 0.00% | -20.0% |
| Q4 2016 | $1,384,000 | +13.7% | 9,411 | -2.3% | 0.01% | 0.0% |
| Q3 2016 | $1,217,000 | -8.2% | 9,629 | -18.1% | 0.01% | 0.0% |
| Q2 2016 | $1,326,000 | +11.3% | 11,757 | +2.8% | 0.01% | 0.0% |
| Q1 2016 | $1,191,000 | -0.4% | 11,437 | +7.8% | 0.01% | 0.0% |
| Q4 2015 | $1,196,000 | +24.5% | 10,605 | +20.9% | 0.01% | 0.0% |
| Q3 2015 | $961,000 | +11.2% | 8,773 | -2.8% | 0.01% | +25.0% |
| Q2 2015 | $864,000 | +4.1% | 9,027 | +1.3% | 0.00% | 0.0% |
| Q1 2015 | $830,000 | +13733.3% | 8,915 | +12820.3% | 0.00% | – |
| Q4 2014 | $6,000 | 0.0% | 69 | -29.6% | 0.00% | – |
| Q3 2014 | $6,000 | 0.0% | 98 | 0.0% | 0.00% | – |
| Q2 2014 | $6,000 | 0.0% | 98 | 0.0% | 0.00% | – |
| Q1 2014 | $6,000 | -50.0% | 98 | -46.2% | 0.00% | – |
| Q4 2013 | $12,000 | 0.0% | 182 | -1.1% | 0.00% | – |
| Q3 2013 | $12,000 | 0.0% | 184 | +10.8% | 0.00% | – |
| Q2 2013 | $12,000 | – | 166 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |